一家致力於推進新藥開發進程的國際性受託研究機構 (CRO) 和科學諮詢合作夥伴
立足臨床試驗，護航人類健康未來。
協同合作共進，科創驅動前行。
深耕產業標竿，鑄就卓越口碑。
深耕臨床科研數十載，引領產業發展標竿。
Owing to its large population base, Asia may account for over 40% of the estimated global incidence of Follicular Lymphoma, with China, Japan and India collectively contributing to over a quarter of the cases.
